Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2023-05-06

Clinical Trial Update: Electroencephalogram (EEG) Enhanced Transcranial Magnetic Stimulation (eTMS) for Chronic Trauma and Stressor-Related Disorders (TSRD) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for EEG-enhanced transcranial magnetic stimulation (eTMS) targeting trauma and stressor-related disorders, currently in Phase 2/Phase 3 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EEG-enhanced transcranial magnetic stimulation (eTMS)

Snippet

Sponsor: Marcia Bockbrader, MD PhD | Conditions: Trauma and Stressor Related Disorders | Phase 2, Phase 3 | Status: UNKNOWN